TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹17,686 Cr | ₹2,088 Cr | ₹2,224 Cr | ₹2,823 Cr | ₹2,238 Cr |
What is the latest Total Non-Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹17,686 Cr |
| Mar2025 | ₹2,088 Cr |
| Mar2024 | ₹2,224 Cr |
| Mar2023 | ₹2,823 Cr |
| Mar2022 | ₹2,238 Cr |
How is Total Non-Current Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹17,686 Cr | 747.13 | |
| Mar2025 | ₹2,088 Cr | -6.13 | |
| Mar2024 | ₹2,224 Cr | -21.21 | |
| Mar2023 | ₹2,823 Cr | 26.12 | |
| Mar2022 | ₹2,238 Cr | - | |
Compare Total Non-Current Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹181,144.6 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,376.0 Cr | 2.1% | 7.1% | -0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -4.5% |
-4% |
35.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses